date/time interval
- September 30, 2024 - September 29, 2027
Characterizing 3''-UTR biology as a mechanism of therapy response in high risk prostate cancer.
Grant
Overview
awarded by
administered by
sponsor award ID
- HT9425-23-1-0310
Affiliation
contributor
- Barbieri, Christopher Co-Investigator 2024 - 2027
- Imada, Eddie Principal Investigator 2024 - 2027
- Loda, Massimo Key Personnel 2024 - 2027
- Marchionni, Luigi Co-Investigator 2024 - 2027
- Sabuncu, Mert Co-Investigator 2024 - 2027